This Fund is Soft Closed and is not currently available to new investors

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
US$545.7mAUM

AUM 31.12.2019

Holdings
67.92% Active Share
As at 31.12.2019
US$27.70
US$ Class I Dist
NAV per share 16.01.2020
NASDAQ BiotechnologyIndex
As at 31.12.2019

Countries in which this fund is available

Please click on each country to see share class availability